Literature DB >> 17825339

Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif.

Sandra Kao1, Ritu Goila-Gaur, Eri Miyagi, Mohammad A Khan, Sandrine Opi, Hiroaki Takeuchi, Klaus Strebel.   

Abstract

HIV-1 Vif regulates viral infectivity by inhibiting the encapsidation of APOBEC3G (APO3G) through proteasomal degradation of the protein. Here we compared various Vif proteins for their ability to induce APO3G degradation and rescue viral infectivity. We found that Vif expressed from proviral vectors caused relatively inefficient degradation of APO3G in HeLa cells yet was very effective in inhibiting APO3G's antiviral activity. On the other hand, Vif expressed autonomously from a codon-optimized vector caused very efficient APO3G degradation and also effectively inhibited APO3G's antiviral effects. In contrast, a Vif chimera containing an N-terminal fluorescent tag efficiently induced APO3G degradation but was unable to restore viral infectivity. The lack of a direct correlation between APO3G degradation and rescue of viral infectivity suggests that these two properties of Vif are functionally separable. Our data imply that intracellular degradation of APO3G may not be the sole activity of Vif required for the production of infectious virions from APO3G-expressing cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825339      PMCID: PMC2129170          DOI: 10.1016/j.virol.2007.08.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

Authors:  Andrew Mehle; Joao Goncalves; Mariana Santa-Marta; Mark McPike; Dana Gabuzda
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

2.  Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization.

Authors:  Michael J Wichroski; Kozi Ichiyama; Tariq M Rana
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

3.  Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.

Authors:  Edmund N C Newman; Rebecca K Holmes; Heather M Craig; Kevin C Klein; Jaisri R Lingappa; Michael H Malim; Ann M Sheehy
Journal:  Curr Biol       Date:  2005-01-26       Impact factor: 10.834

4.  The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells.

Authors:  J H Simon; R A Fouchier; T E Southerling; C B Guerra; C K Grant; M H Malim
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Monomeric APOBEC3G is catalytically active and has antiviral activity.

Authors:  Sandrine Opi; Hiroaki Takeuchi; Sandra Kao; Mohammad A Khan; Eri Miyagi; Ritu Goila-Gaur; Yasumasa Iwatani; Judith G Levin; Klaus Strebel
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes.

Authors:  Mohammad A Khan; Sandra Kao; Eri Miyagi; Hiroaki Takeuchi; Ritu Goila-Gaur; Sandrine Opi; Clay L Gipson; Tristram G Parslow; Hinh Ly; Klaus Strebel
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.

Authors:  Ya-Lin Chiu; Vanessa B Soros; Jason F Kreisberg; Kim Stopak; Wes Yonemoto; Warner C Greene
Journal:  Nature       Date:  2005-04-13       Impact factor: 49.962

8.  Subcellular localization of the Vif protein of human immunodeficiency virus type 1.

Authors:  J Goncalves; P Jallepalli; D H Gabuzda
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.

Authors:  H Liu; X Wu; M Newman; G M Shaw; B H Hahn; J C Kappes
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells.

Authors:  Sandra Kao; Eri Miyagi; Mohammad A Khan; Hiroaki Takeuchi; Sandrine Opi; Ritu Goila-Gaur; Klaus Strebel
Journal:  Retrovirology       Date:  2004-09-17       Impact factor: 4.602

View more
  27 in total

Review 1.  HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors.

Authors:  Silke Wissing; Nicole L K Galloway; Warner C Greene
Journal:  Mol Aspects Med       Date:  2010-06-09

2.  HIV-1 Vif interaction with APOBEC3 deaminases and its characterization by a new sensitive assay.

Authors:  Iris Cadima-Couto; Nuno Saraiva; Ana Catarina C Santos; Joao Goncalves
Journal:  J Neuroimmune Pharmacol       Date:  2011-01-29       Impact factor: 4.147

3.  Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Authors:  Judd F Hultquist; Reuben S Harris
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

4.  Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet.

Authors:  Mario Perkovic; Stanislaw Schmidt; Daniela Marino; Rebecca A Russell; Benjamin Stauch; Henning Hofmann; Ferdinand Kopietz; Björn-Philipp Kloke; Jörg Zielonka; Heike Ströver; Johannes Hermle; Dirk Lindemann; Vinay K Pathak; Gisbert Schneider; Martin Löchelt; Klaus Cichutek; Carsten Münk
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

5.  Hydrodynamic and functional analysis of HIV-1 Vif oligomerization.

Authors:  Stephen M Techtmann; Rodolfo Ghirlando; Sandra Kao; Klaus Strebel; Ernest L Maynard
Journal:  Biochemistry       Date:  2012-03-05       Impact factor: 3.162

6.  Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.

Authors:  Robert C Walker; Mohammad A Khan; Sandra Kao; Ritu Goila-Gaur; Eri Miyagi; Klaus Strebel
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

7.  CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.

Authors:  Eri Miyagi; Sandra Kao; Venkat Yedavalli; Klaus Strebel
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  APOBEC3G-independent reduction in virion infectivity during long-term HIV-1 replication in terminally differentiated macrophages.

Authors:  Eri Miyagi; Franziska Schwartzkopff; Ronald Plishka; Alicia Buckler-White; Kathleen A Clouse; Klaus Strebel
Journal:  Virology       Date:  2008-08-03       Impact factor: 3.616

Review 9.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

10.  HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes.

Authors:  Ritu Goila-Gaur; Mohammad A Khan; Eri Miyagi; Sandra Kao; Sandrine Opi; Hiroaki Takeuchi; Klaus Strebel
Journal:  Virology       Date:  2007-11-19       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.